TickerFactsScreenerDevelopers

RELMADA THERAPEUTICS, INC. (RLMD) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $21.58M2014: $26.87M2015: $15.58M2016: $3.20M2017: $1.38M2018: $8.56M2019: $1.46M2020: $12.60M2021: $15.06M2022: $12.47M2023: $12.19M2024: $10.30M2025: $7.49M$7.49M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$7.49M-27.2%
2024$10.30M-15.6%
2023$12.19M-2.2%
2022$12.47M-17.2%
2021$15.06M+19.5%
2020$12.60M+764.5%
2019$1.46M-83.0%
2018$8.56M+521.9%
2017$1.38M-57.0%
2016$3.20M-79.5%
2015$15.58M-42.0%
2014$26.87M+24.5%
2013$21.58M—